Betta Pharmaceuticals Co., Ltd. (SHE:300558)

China · Delayed Price · Currency is CNY

51.15

+2.24 (4.58%)

Jun 9, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Manufacturing	3.61B	2.89B	2.46B	2.38B	2.25B
Pharmaceutical Manufacturing Growth	24.81%	17.74%	3.35%	5.82%	20.08%
Total	3.61B	2.89B	2.46B	2.38B	2.25B
Total Growth	24.81%	17.74%	3.35%	5.82%	20.08%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	3.59B	2.86B	-	-	2.25B
China Growth	25.64%	-	-	-	20.48%
Foreign	20.78M	35.64M	-	-	411.08K
Foreign Growth	-41.69%	-	-	-	-93.70%
Total	3.61B	2.89B	-	-	2.25B
Total Growth	24.81%	-	-	-	20.08%

Source: S&P Global Market Intelligence.